Video encyclopedia



The safety of nivolumab for advanced melanoma


Nivolumab in Renal Cell Carcinoma


Nivolumab With or Without Ipilimumab in Gastroesophageal Junction Cancer


Neoadjuvant ipilimumab plus nivolumab in stage III melanoma


FRACTION-RCC: Evaluating nivolumab plus ipilimumab in patients with treatment-refractory advance...

Nivolumab, marketed as Opdivo, is a medication used to treat cancer. It is used as a first line treatment for inoperable or metastatic melanoma in combination with ipilimumab if the cancer does not have a mutation in BRAF, as a second-line treatment following treatment with ipilimumab and if the cancer has a mutation in BRAF, with a BRAF inhibitor, as a second-line treatment for squamous non-small cell lung cancer, and as a second-line treatment for renal cell carcinoma.
Explore contextually related video stories in a new eye-catching way. Try Combster now!
  • Medical use 

  • Side effects 

  • Physical properties 

  • History 

  • Research